Original Source(s)
Related Content
This Week’s CGT News: Bristol Myers Ends Cellares Manufacturing Agreement
A first-in-human study reduces stem-cell collection and manufacturing times, Bristol Myers ends its Breyanzi agreement with Cellares, and two approaches strengthen CAR T-cell activity against solid tumors
August 31, 2026
-
5 min
Coding for Ocular Tumors
Ocular tumor coding can be challenging because ocular oncology often involves evolving lesions, diagnostic uncertainty, and terminology that does not always translate cleanly into ICD-10-CM codes. Understanding how to distinguish benign, malignant, in situ, and uncertain histologic behavior neoplasms is essential for accurate coding, medical necessity, and audit defensibility.
September 1, 2026
-
4 min
